Article
Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
Neurobiology of aging - 1 Dec 2012
Durairajan Siva Sundara Kumar, Liu Liang-Feng, Lu Jia-Hong, Chen Lei-Lei, Yuan Qiuju, Chung Sookja K, Huang Ling, Li Xing-Shu, Huang Jian-Dong, Li Min
Abstract excerpt
The accumulation of β-amyloid (Aβ) peptide derived from abnormal processing of amyloid precursor protein (APP) is a common pathological hallmark of Alzheimer's disease (AD) brains. In this study, we evaluated the therapeutic effect of berberine (BBR) extracted from Coptis chinensis Franch, a Chinese medicinal herb, on the neuropathology and cognitive impairment in TgCRND8 mice, a well established transgenic mouse...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
